Changes

|}

===Global Revenue Data Of products===

<table cellpadding="3" cellspacing="0">

<tr>

</tr>

</table>

==Biosimilars Of Interferons==

Biosimilar interferons are the major drug class in the recombinant non-glycosylated proteins market due to their extensive use in the treatment of various genetic and environmental disorders. The overall biosimilar market for interferons is categorized into the submarkets for alpha, beta, and gamma interferons, all of which are used extensively in the treatment of various conditions such as lymphoma, hairy cell leukemia, and multiple sclerosis.